Tag:
Jeremy Levin
Latest Headlines
Latest Headlines
New Teva chief slashes sales forecast by $1B
This year's revenue won't come in at the $22 billion previously projected, he said, and nor will the company be as profitable as earlier forecasts indicated.
Is Teva considering a jump to NYSE?
Teva Pharmaceutical Industries ( $TEVA ), the Israeli generics giant, is reportedly mulling over the idea of jumping to the New York Stock Exchange after three decades of trading on Nasdaq, Haaretz is reporting.
Teva scrambling toward post-Copaxone future
Teva Pharmaceutical Industries ( $TEVA ) has been the world's biggest generics player for years. Problem is, it's trying to be more than that. And makeovers take time. Midway through last year,...
Teva looks set for a new round of M&A deals
Don't be too surprised if Teva starts to make fresh headlines on the M&A side of the business. CEO Shlomo Yanai is telling reporters the company is acutely aware of just how badly it needs to
Teva lures Levin to repeat BMS dealmaking
The changing of the guard at Teva Pharmaceutical Industries ( $TEVA ) couldn't more clearly signal a change in the generics giant's worldview. Under the current CEO, Shlomo Yanai, Teva more than
